MacroGenics Operating Income from 2010 to 2026

MGNX Stock

USD 1.73 0.02 1.14%

MacroGenics Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income will likely drop to about -104.5 M in 2026. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit MacroGenics generates from its operations. View All Fundamentals

Operating Income

First Reported

2011-12-31

Previous Quarter

-36.8 M

Current Value

18.6 M

Quarterly Volatility

32.6 M

Yuan Drop

Covid

Interest Hikes

Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.6 M, Interest Expense of 1.3 M or Selling General Administrative of 85.8 M, as well as many indicators such as Price To Sales Ratio of 1.5, Dividend Yield of 0.0 or PTB Ratio of 1.66. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.

Build AI portfolio with MacroGenics Stock

Check out the analysis of MacroGenics Correlation against competitors.

For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

The evolution of Operating Income for MacroGenics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how MacroGenics compares to historical norms and industry peers.

Latest MacroGenics' Operating Income Growth Pattern

Below is the plot of the Operating Income of MacroGenics over the last few years. Operating Income is the amount of profit realized from MacroGenics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of MacroGenics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. MacroGenics' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

MacroGenics Operating Income Regression Statistics

	Arithmetic Mean	(82,830,222)
	Coefficient Of Variation	(87.77)
	Mean Deviation	63,650,637
	Median	(99,520,200)
	Standard Deviation	72,701,041
	Sample Variance	5285.4T
	Range	211M
	R-Value	(0.74)
	Mean Square Error	2553.8T
	R-Squared	0.55
	Significance	0.0007
	Slope	(10,648,125)
	Total Sum of Squares	84567.1T

MacroGenics Operating Income History

	2026	-104.5 M
	2025	-99.5 M
	2024	-110.6 M
	2023	-168.2 M
	2022	-121.4 M
	2021	-202.8 M
	2020	-131.1 M

Other Fundumenentals of MacroGenics

Non Operating Income Net Other

MacroGenics Operating Income component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Short Term Investments	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.94	-0.74	-0.61	-0.51	-0.14	0.37	0.23	0.99	-0.29	0.79	0.76	0.88	0.66	0.66	0.31	-0.77	-0.7	-0.3	-0.38	0.39
Total Stockholder Equity	0.94		-0.79	-0.66	-0.21	-0.21	0.24	-0.11	0.96	-0.19	0.56	0.66	0.96	0.73	0.39	0.03	-0.59	-0.49	0.01	-0.09	0.1
Current Deferred Revenue	-0.74	-0.79		0.48	0.18	0.55	-0.2	0.09	-0.78	0.12	-0.5	-0.4	-0.73	-0.6	-0.31	-0.05	0.45	0.26	0.1	0.12	-0.13
Net Debt	-0.61	-0.66	0.48		-0.01	0.43	-0.09	0.11	-0.64	0.01	-0.3	-0.46	-0.64	-0.07	-0.11	0.01	0.24	0.42	-0.04	0.03	0.09
Retained Earnings	-0.51	-0.21	0.18	-0.01		-0.23	-0.39	-0.86	-0.42	0.27	-0.87	-0.48	-0.15	-0.12	-0.95	-0.86	0.76	0.74	0.9	0.9	-0.95
Accounts Payable	-0.14	-0.21	0.55	0.43	-0.23		-0.03	0.21	-0.18	-0.19	0.0	-0.06	-0.12	0.03	0.2	0.2	-0.06	-0.06	-0.03	-0.1	0.29
Net Receivables	0.37	0.24	-0.2	-0.09	-0.39	-0.03		0.39	0.27	-0.16	0.41	0.45	0.15	0.02	0.43	0.25	-0.46	-0.53	-0.3	-0.33	0.25
Total Liab	0.23	-0.11	0.09	0.11	-0.86	0.21	0.39		0.14	-0.28	0.68	0.32	-0.17	-0.14	0.83	0.81	-0.57	-0.64	-0.92	-0.85	0.86
Total Current Assets	0.99	0.96	-0.78	-0.64	-0.42	-0.18	0.27	0.14		-0.26	0.72	0.67	0.91	0.71	0.58	0.25	-0.69	-0.6	-0.22	-0.29	0.32
Short Term Debt	-0.29	-0.19	0.12	0.01	0.27	-0.19	-0.16	-0.28	-0.26		-0.16	-0.28	-0.32	-0.24	-0.31	-0.2	0.33	0.28	0.2	0.22	-0.22
Common Stock	0.79	0.56	-0.5	-0.3	-0.87	0.0	0.41	0.68	0.72	-0.16		0.65	0.43	0.36	0.95	0.68	-0.82	-0.76	-0.74	-0.77	0.81
Property Plant Equipment	0.76	0.66	-0.4	-0.46	-0.48	-0.06	0.45	0.32	0.67	-0.28	0.65		0.63	0.3	0.59	0.26	-0.81	-0.87	-0.34	-0.51	0.33
Net Tangible Assets	0.88	0.96	-0.73	-0.64	-0.15	-0.12	0.15	-0.17	0.91	-0.32	0.43	0.63		0.69	0.3	-0.02	-0.54	-0.45	0.08	-0.04	0.05
Short Term Investments	0.66	0.73	-0.6	-0.07	-0.12	0.03	0.02	-0.14	0.71	-0.24	0.36	0.3	0.69		0.29	-0.06	-0.41	-0.12	0.09	0.09	0.04
Capital Surpluse	0.66	0.39	-0.31	-0.11	-0.95	0.2	0.43	0.83	0.58	-0.31	0.95	0.59	0.3	0.29		0.75	-0.81	-0.78	-0.83	-0.83	0.91
Deferred Long Term Liab	0.31	0.03	-0.05	0.01	-0.86	0.2	0.25	0.81	0.25	-0.2	0.68	0.26	-0.02	-0.06	0.75		-0.62	-0.61	-0.88	-0.86	0.86
Long Term Debt Total	-0.77	-0.59	0.45	0.24	0.76	-0.06	-0.46	-0.57	-0.69	0.33	-0.82	-0.81	-0.54	-0.41	-0.81	-0.62		0.87	0.61	0.68	-0.64
Long Term Investments	-0.7	-0.49	0.26	0.42	0.74	-0.06	-0.53	-0.64	-0.6	0.28	-0.76	-0.87	-0.45	-0.12	-0.78	-0.61	0.87		0.61	0.7	-0.61
Net Invested Capital	-0.3	0.01	0.1	-0.04	0.9	-0.03	-0.3	-0.92	-0.22	0.2	-0.74	-0.34	0.08	0.09	-0.83	-0.88	0.61	0.61		0.96	-0.88
Net Working Capital	-0.38	-0.09	0.12	0.03	0.9	-0.1	-0.33	-0.85	-0.29	0.22	-0.77	-0.51	-0.04	0.09	-0.83	-0.86	0.68	0.7	0.96		-0.86
Capital Stock	0.39	0.1	-0.13	0.09	-0.95	0.29	0.25	0.86	0.32	-0.22	0.81	0.33	0.05	0.04	0.91	0.86	-0.64	-0.61	-0.88	-0.86

Click cells to compare fundamentals

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	-99.5 M	-104.5 M
Non Operating Income Net Other	1.9 M	2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

MacroGenics Operating Income from 2010 to 2026

Latest MacroGenics' Operating Income Growth Pattern

MacroGenics Operating Income Regression Statistics

MacroGenics Operating Income History

Other Fundumenentals of MacroGenics

MacroGenics Operating Income component correlations

About MacroGenics Financial Statements

Also Currently Popular

Additional Tools for MacroGenics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY